Items Tagged ‘Dr. Richard Weinshilboum’
October 5, 2017
#CIMCon17: learn from experts moving genomic discoveries into patient care
By Sharon Rosen 
Mayo Clinic is a leader in moving important advancements in precision medicine from the laboratory into patient care, offering hope and healing. The Individualizing Medicine Conference: Advancing Care Through Genomics gives medical providers and scientists the opportunity to learn firsthand the newest ways genomic medicine is improving care for patients. The Mayo Clinic Center for […]
Tags: #CIMCon17, #Consumer genomics, #Dr. David Ledbetter, #Dr. David Relman, #Dr. Judy Cho, #Dr. Rachel Tyndale, #Dr. Rob Knight, #Dr. Robert Green, #Dr. Stephanie Devaney, #Dr. William Gahl, #genomic testing, #Home DNA tests
July 3, 2017
Trying to quit smoking? Genetics may help find the right plan for success
By Sharon Rosen
After trying different methods, why do many people have difficulty quitting smoking? That’s a question Rachel Tyndale, Ph.D., is asking as part of her research into smoking cessation therapy. As senior scientist and head of the Pharmacogenetics Lab in the Campbell Family Mental Health Research Institute at University of Toronto, Dr. Tyndale is using molecular […]
Tags: #CIMCon17, #DNA analysis, #Dr. J. Steven Leeder, #Dr. Rachel Tyndale, #drug-gene reactions, #Individualizing Medicine 2017, #preemptive pharmacogenomics, #smoking cessation, center for individualized medicine, DNA Sequencing, Dr. Eric Matey, Dr. Liewei Wang
June 30, 2017
Pharmacogenomics – striving for safer, more effective drugs for you
By Sharon Rosen
At Mayo Clinic, pharmacogenomics – how your genes impact the way you process medications – is helping doctors to take the guess work out of selecting safer, more effective treatment for patients. Mayo researchers have been leaders in developing DNA tests and identifying drug-gene interactions that affect a patient’s response to many medications, such as […]
Tags: #CIMCon17, #drug safety, #drug-gene reactions, #Karen Daggett, center for individualized medicine, Dr. Eric Matey, Dr. Liewei Wang, Dr. Richard Weinshilboum, Heart Disease, mayo clinic, Mayo Clinic Pharmacogenomics Program, medical research
November 10, 2016
By Sharon Rosen
One size does not fit all – especially when it comes to medications. Pharmacogenomics is the study of how your individual genetic characteristics impact your response to medications. The RIGHT study, done at Mayo Clinic, found that 99 percent of people studied had a genetic variation that affects how they respond to a drug therapy. […]
Tags: #Dr. Robert Freimuth, #drug-gene reactions, #Genetic data, #PrecisionMedicine, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, mayo clinic, PGx, pharmacogenomics
October 25, 2016
Getting It RIGHT — Individualized Medicine Is Getting Very Personal
By Sharon Rosen
10,000 people help answer a basic individualized medicine question Nearly 1 out of every 3 American adults has high blood pressure. About 70 percent of them take medication for their condition, but only half have it under control. Why? The answer gets to the heart of individualized medicine: Because each person has a unique genetic […]
Tags: #Dr. Jennifer St. Sauver, #electronic medical record, #Mayo Clinic Biobank, #Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, #PrecisionMedicine, center for individualized medicine, Dr. Richard Weinshilboum, Genetic Testing, mayo clinic, PGx, pharmacogenomics, RIGHT Protocol
July 7, 2016
Mayo Clinic Researcher Receives Distinguished Award for Pharmacogenomics Research
By Sharon Rosen
Liewei Wang, M.D., Ph.D., Mayo Clinic professor of Pharmacology, received the highly prestigious Leon I. Goldberg Early Investigator Award for her pharmacogenomics research. Pharmacogenomics is the study of how a patient’s genes affect the body’s response to medication. She is the second Mayo Clinic faculty member to have received the award by the American Society for […]
Tags: American Society for Clinical Pharmacology and Therapeutics, biomarkers, center for individualized medicine, Dr. James Ingle, Dr. Judy Boughey, Dr. Liewei Wang, Dr. Matthew Goetz, Dr. Richard Weinshilboum, Leon I. Goldberg Early Investigator Award, mayo clinic, Mayo Clinic Center for Individualized Medicine, pharmacogenomics
April 21, 2016
Mayo Clinic Research Information Center Presents ‘Changing Lives Through Research’
By Jeff Briggs
National DNA Day is coming to Mayo Clinic a couple of days late. But biomedical research is often like that: you start towards your target, meander around like a person trying to herd cats, and then you analyze your results and discover something else entirely. National DNA Day is a holiday celebrated on April 25 […]
Tags: center for individualized medicine, Changing lives through research, DNA Day, Dr. Marina Walther-Antonio, Dr. Nicholas Chia, Dr. Purna Kashyap, Dr. Richard Weinshilboum, Dr. Timothy Curry, Human Genome Project, microbiome, National DNA Day, pharmacogenomics
February 22, 2016
Precision Medicine, Part Two: Benefits of Mapping the Human Genome
By Jeff Briggs
This is part two of a three-part series on What Is Precision Medicine, another of the Center for Individualized Medicine’s attempt to explain and introduce precision medicine to an audience that may just be coming to the topic. Part one explored “From Double Helix to Health Care,” and part three, coming next week, will look […]
Tags: breast cancer, cancer, center for individualized medicine, Dr. Diana Bianchi, Dr. Richard Weinshilboum, Dr. Stephen Quake, individualized medicine, personalized medicine, pharmacogenomics, Precision Medicine
January 29, 2016
By Jeff Briggs
Pharmacogenomics. Try saying that fast three times in a row. That’s probably why all of us here at the Center for Individualized Medicine, or CIM as we commonly refer to it, probably just call it PGx. Occasionally on the CIM blog, we like to take a step back from our updates on genomic biomarkers in […]
Tags: center for individualized medicine, Dr. Richard Weinshilboum, IndividualizedMedicine, personalized medicine, PGx, pharmacogenomics, Precision Medicine
December 29, 2015
Delivering on the Promise of Precision Medicine: 2015 Year in Review
By Jeff Briggs
2015 was the year of precision medicine. “Individualized medicine is already providing profound changes in how we treat patients,” said Keith Stewart, M.B., Ch.B., the Carlson and Nelson Endowed Director of the Center for Individualized Medicine, as he opened the 2015 Individualizing Medicine Conference. “It is offering hope to people who had no hope, […]
Tags: Biobank, biomarkers, breast cancer, center for individualized medicine, diagnostic odyssey, Dr. Aleksandar Sekulic, Dr. J. Craig Venter, Dr. Keith Stewart, Dr. Konstantinos Lazaridis, Dr. Richard Weinshilboum, Genome Sequencing, Gianrico Farrugia